Cryoport Inc (CYRX)
Official siteINDUSTRIALS • INTEGRATED FREIGHT & LOGISTICS • NASDAQ
Market Cap: $1.01B
Last updated: Nov 17, 2026 at 11:04 AM ET
Cryoport Inc (CYRX) Financials: Revenue, Profit and Cash Flow
Cryoport reported revenue of $176.18M for the fiscal year ended Dec 31, 2025, down 24.5% from the year before. That year, net income was $78.30M with a net margin of 44.4%, operating cash flow was -$8.58M and free cash flow was -$28.09M. The quarter ended Sep 30, 2026 had revenue of $50.22M and net income of -$10.85M.
Revenue and Margins
The operating margin was -20.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $7.68M, a compound annual rate of 41.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $176.18M | -24.5% | 47.1% | -20.9% | 44.4% |
| Dec 2024 | $233.25M | -1.7% | 42.6% | -49.4% | -42.7% |
| Dec 2023 | $237.28M | +6.6% | 43.8% | -13.4% | -15.7% |
| Dec 2022 | $222.61M | 0.0% | 43.4% | -8.0% | -123.8% |
| Dec 2021 | $222.61M | +182.9% | 43.4% | -8.0% | -123.8% |
| Dec 2020 | $78.70M | +131.9% | 46.2% | -38.1% | -41.5% |
| Dec 2019 | $33.94M | +72.9% | 51.1% | -52.1% | -54.0% |
| Dec 2018 | $19.63M | +64.2% | 52.2% | -44.0% | -48.7% |
| Dec 2017 | $11.95M | +55.7% | 49.9% | -66.0% | -66.1% |
| Dec 2016 | $7.68M | N/A | 40.4% | -114.2% | -170.8% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $176.18M | $233.25M | $237.28M | $222.61M | $222.61M | $78.70M | $33.94M | $19.63M | $11.95M | $7.68M |
| Cost of revenue | $93.12M | $133.92M | $133.40M | $126.03M | $126.03M | $42.36M | $16.59M | $9.39M | $5.99M | $4.58M |
| Gross profit | $83.05M | $99.33M | $103.87M | $96.58M | $96.58M | $36.33M | $17.35M | $10.24M | $5.97M | $3.10M |
| Research and development | $17.04M | $18.04M | $15.72M | $16.84M | $16.84M | $9.48M | $3.74M | $1.84M | $1.21M | $598.11K |
| Operating income | -$36.81M | -$115.16M | -$31.90M | -$17.83M | -$17.83M | -$30.01M | -$17.68M | -$8.64M | -$7.89M | -$8.77M |
| Net income | $78.30M | -$99.59M | -$37.33M | -$275.53M | -$275.53M | -$32.69M | -$18.33M | -$9.56M | -$7.90M | -$13.11M |
| EBITDA | -$2.10M | -$63.09M | -$1.47M | N/A | N/A | -$20.31M | -$14.49M | -$8.61M | -$7.21M | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50.22M | $48.97M | $47.80M | $45.45M | $44.23M | $45.45M | $41.04M | $59.53M | $56.66M | $39.71M | $37.29M | $57.26M |
| Gross profit | $23.83M | $22.82M | $21.91M | $21.71M | $21.32M | $21.38M | $18.64M | $27.28M | $25.39M | $17.66M | $15.06M | $23.26M |
| Operating income | -$8.80M | -$10.04M | -$9.61M | -$10.03M | -$9.93M | -$9.65M | -$9.48M | -$13.93M | -$16.43M | -$78.03M | -$17.51M | -$69.87M |
| Net income | -$10.85M | -$8.26M | -$9.43M | -$11.64M | -$6.94M | $105.18M | -$11.98M | -$18.68M | $805.00K | -$77.99M | -$18.89M | -$62.39M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $190.90M by $59.59M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $764.99M | $703.49M | $957.74M | $1.04B | $1.11B | $552.40M | $135.87M | $56.62M | $20.26M | $8.11M |
| Current assets | $476.17M | $341.57M | $535.11M | $604.18M | $693.52M | $147.16M | $102.97M | $51.77M | $17.30M | $6.10M |
| Cash and equivalents | $250.49M | $45.29M | $46.35M | $36.59M | $139.10M | $36.87M | $47.23M | $37.33M | $15.04M | $2.79B |
| Total liabilities | $262.35M | $301.59M | $468.72M | $482.91M | $471.14M | $169.71M | $9.59M | $18.07M | $2.38M | $2.43M |
| Short-term debt | $189.81M | $20.35M | $5.81M | $3.91M | $3.60M | $2.29M | $691.00K | $23.19K | $0 | $651.93K |
| Long-term debt | $1.09M | $185.03M | $379.89M | $407.06M | $405.26M | $116.26M | N/A | $14.71M | N/A | N/A |
| Shareholder equity | $502.64M | $401.90M | $489.02M | $555.84M | $641.83M | $382.70M | $126.28M | $38.55M | $17.89M | $5.68M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $750.95M | $756.20M | $763.61M | $764.99M | $774.33M | $699.84M | $699.84M | $703.49M | $701.76M | $852.34M | $942.85M | $957.74M |
| Total liabilities | $267.43M | $265.50M | $268.62M | $262.35M | $261.06M | $301.03M | $301.03M | $301.59M | $283.19M | $452.25M | $470.66M | $468.72M |
| Cash and equivalents | $279.18M | $269.27M | $272.91M | $250.49M | $255.81M | $36.10M | $36.10M | $45.29M | $44.66M | $46.46M | $49.66M | $46.35M |
| Shareholder equity | $483.51M | $490.70M | $494.99M | $502.64M | $513.27M | $398.81M | $398.81M | $401.90M | $418.57M | $400.10M | $472.19M | $489.02M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$8.58M | -$16.32M | -$757.00K | -$1.85M | $8.13M | -$14.87M | -$1.32M | -$3.35M | -$3.58M | -$5.72M |
| Capital expenditures | $19.50M | $17.25M | $44.90M | $24.20M | $25.01M | $9.67M | $5.41M | $2.96M | $1.80M | $1.07M |
| Free cash flow | -$28.09M | -$33.58M | -$45.66M | -$26.05M | -$16.88M | -$24.54M | -$6.73M | -$6.31M | -$5.38M | -$6.79M |
| Dividends paid | $8.00M | $8.00M | $8.00M | $8.00M | $8.20M | $2.84M | N/A | N/A | N/A | $1.07B |
| Investing cash flow | $250.32M | $176.81M | $36.05M | -$59.68M | -$469.25M | -$382.31M | -$62.93M | -$12.88M | -$1.80M | -$1.07M |
| Financing cash flow | -$21.07M | -$161.53M | -$23.80M | -$39.17M | $564.34M | $385.58M | $74.15M | $38.53M | $15.90M | $6.14M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.21M | $1.13M | $3.73M | $919.00K | $2.19M | -$7.34M | -$4.34M | -$5.48M | $447.00K | -$8.03M | -$3.27M | $2.48M |
| Capital expenditures | $5.25M | $8.80M | $10.28M | $4.94M | $4.28M | $4.35M | $4.08M | $5.64M | $1.50M | $5.77M | $4.77M | $12.24M |
| Free cash flow | -$40.00K | -$7.67M | -$6.55M | -$4.03M | -$2.09M | -$11.70M | -$8.42M | -$11.12M | -$1.05M | -$13.79M | -$8.03M | -$9.76M |
Frequently Asked Questions About CYRX
What is Cryoport's annual revenue?
Cryoport reported revenue of $176.18M for the fiscal year ended Dec 31, 2025.
How fast is Cryoport's revenue growing?
Revenue was down 24.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -7.5%.
Is Cryoport profitable?
Yes. Cryoport reported net income of $78.30M for the fiscal year ended Dec 31, 2025, with a net margin of 44.4%.
How much free cash flow does CYRX generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$8.58M minus capital expenditures of $19.50M produced free cash flow of -$28.09M.
How much debt does Cryoport have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.09M, short-term debt of $189.81M and cash and equivalents of $250.49M.
CYRX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors